annual EBIT:
-$2.29B-$1.49B(-186.45%)Summary
- As of today (May 29, 2025), BIO annual earnings before interest & taxes is -$2.29 billion, with the most recent change of -$1.49 billion (-186.45%) on December 31, 2024.
- During the last 3 years, BIO annual EBIT has fallen by -$7.74 billion (-142.08%).
- BIO annual EBIT is now -142.08% below its all-time high of $5.45 billion, reached on December 31, 2021.
Performance
BIO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$95.40M+$992.13M(+110.64%)Summary
- As of today (May 29, 2025), BIO quarterly earnings before interest & taxes is $95.40 million, with the most recent change of +$992.13 million (+110.64%) on March 31, 2025.
- Over the past year, BIO quarterly EBIT has dropped by -$408.00 million (-81.05%).
- BIO quarterly EBIT is now -98.10% below its all-time high of $5.02 billion, reached on September 30, 2021.
Performance
BIO quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$2.70B-$408.00M(-17.79%)Summary
- As of today (May 29, 2025), BIO TTM earnings before interest & taxes is -$2.70 billion, with the most recent change of -$408.00 million (-17.79%) on March 31, 2025.
- Over the past year, BIO TTM EBIT has dropped by -$2.31 billion (-584.86%).
- BIO TTM EBIT is now -131.52% below its all-time high of $8.57 billion, reached on September 30, 2021.
Performance
BIO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BIO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -186.4% | -81.0% | -584.9% |
| 3 y3 years | -142.1% | +102.2% | -1182.3% |
| 5 y5 years | -200.4% | -89.5% | -231.4% |
BIO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -142.1% | +50.9% | -91.3% | +102.2% | -1852.1% | +65.3% |
| 5 y | 5-year | -142.1% | +50.9% | -98.1% | +102.2% | -131.5% | +65.3% |
| alltime | all time | -142.1% | +50.9% | -98.1% | +102.2% | -131.5% | +65.3% |
BIO EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $95.40M(-110.6%) | -$2.70B(+17.8%) |
| Dec 2024 | -$2.29B(+186.4%) | -$896.73M(-202.6%) | -$2.29B(+139.9%) |
| Sep 2024 | - | $873.79M(-131.5%) | -$956.11M(-43.1%) |
| Jun 2024 | - | -$2.77B(-651.1%) | -$1.68B(+326.0%) |
| Mar 2024 | - | $503.40M(+14.2%) | -$394.47M(-50.7%) |
| Dec 2023 | -$800.70M(-82.8%) | $440.72M(+194.8%) | -$800.70M(+478.6%) |
| Sep 2023 | - | $149.50M(-110.0%) | -$138.39M(-71.4%) |
| Jun 2023 | - | -$1.49B(-1631.5%) | -$483.55M(+135.9%) |
| Mar 2023 | - | $97.17M(-91.2%) | -$204.95M(-95.6%) |
| Dec 2022 | -$4.67B(-185.6%) | $1.10B(-663.8%) | -$4.67B(-40.1%) |
| Sep 2022 | - | -$195.66M(-83.8%) | -$7.80B(+202.5%) |
| Jun 2022 | - | -$1.21B(-72.3%) | -$2.58B(+1123.3%) |
| Mar 2022 | - | -$4.36B(+115.3%) | -$210.68M(-103.9%) |
| Dec 2021 | $5.45B(+10.3%) | -$2.03B(-140.4%) | $5.45B(-36.4%) |
| Sep 2021 | - | $5.02B(+334.1%) | $8.57B(+63.6%) |
| Jun 2021 | - | $1.16B(-10.8%) | $5.24B(-1.8%) |
| Mar 2021 | - | $1.30B(+18.7%) | $5.33B(+8.0%) |
| Dec 2020 | $4.94B(+116.2%) | $1.09B(-35.3%) | $4.94B(+8.5%) |
| Sep 2020 | - | $1.69B(+35.0%) | $4.55B(+79.8%) |
| Jun 2020 | - | $1.25B(+38.4%) | $2.53B(+23.2%) |
| Mar 2020 | - | $904.39M(+28.2%) | $2.06B(-10.0%) |
| Dec 2019 | $2.28B(+325.7%) | $705.49M(-314.0%) | $2.28B(+320.0%) |
| Sep 2019 | - | -$329.69M(-142.5%) | $543.89M(-55.8%) |
| Jun 2019 | - | $775.44M(-31.6%) | $1.23B(+53.6%) |
| Mar 2019 | - | $1.13B(-209.5%) | $800.40M(+49.2%) |
| Dec 2018 | $536.62M(+344.2%) | -$1.04B(-390.6%) | $536.62M(-66.9%) |
| Sep 2018 | - | $356.19M(+2.9%) | $1.62B(+24.5%) |
| Jun 2018 | - | $346.06M(-60.2%) | $1.30B(+35.1%) |
| Mar 2018 | - | $869.47M(+1580.8%) | $964.83M(+698.6%) |
| Dec 2017 | $120.82M(+86.0%) | $51.73M(+41.9%) | $120.82M(+154.7%) |
| Sep 2017 | - | $36.46M(+408.9%) | $47.44M(+20.7%) |
| Jun 2017 | - | $7.17M(-71.9%) | $39.30M(-39.2%) |
| Mar 2017 | - | $25.46M(-217.6%) | $64.63M(-0.5%) |
| Dec 2016 | $64.94M(-61.2%) | -$21.65M(-176.5%) | $64.94M(-55.8%) |
| Sep 2016 | - | $28.32M(-12.8%) | $146.82M(-1.9%) |
| Jun 2016 | - | $32.50M(+26.1%) | $149.74M(-7.3%) |
| Mar 2016 | - | $25.77M(-57.2%) | $161.62M(-3.5%) |
| Dec 2015 | $167.54M(+9.0%) | $60.23M(+92.8%) | $167.54M(+6.0%) |
| Sep 2015 | - | $31.24M(-29.6%) | $158.05M(+0.7%) |
| Jun 2015 | - | $44.37M(+40.0%) | $157.00M(-6.0%) |
| Mar 2015 | - | $31.70M(-37.5%) | $166.99M(+8.7%) |
| Dec 2014 | $153.69M(-11.5%) | $50.75M(+68.1%) | $153.69M(-0.5%) |
| Sep 2014 | - | $30.19M(-44.5%) | $154.47M(+2.5%) |
| Jun 2014 | - | $54.36M(+195.5%) | $150.68M(-4.0%) |
| Mar 2014 | - | $18.39M(-64.3%) | $157.03M(-9.6%) |
| Dec 2013 | $173.66M(-38.2%) | $51.53M(+95.2%) | $173.66M(-10.9%) |
| Sep 2013 | - | $26.39M(-56.5%) | $194.90M(-17.2%) |
| Jun 2013 | - | $60.71M(+73.3%) | $235.41M(-7.0%) |
| Mar 2013 | - | $35.02M(-51.9%) | $253.12M(-8.8%) |
| Dec 2012 | $281.02M(-6.0%) | $72.77M(+8.8%) | $277.47M(-7.7%) |
| Sep 2012 | - | $66.90M(-14.7%) | $300.68M(-0.4%) |
| Jun 2012 | - | $78.42M(+32.1%) | $301.89M(+2.9%) |
| Mar 2012 | - | $59.38M(-38.1%) | $293.33M(-1.9%) |
| Dec 2011 | $298.98M(+5.3%) | $95.98M(+40.9%) | $298.98M(+6.5%) |
| Sep 2011 | - | $68.11M(-2.5%) | $280.75M(-1.5%) |
| Jun 2011 | - | $69.86M(+7.4%) | $284.94M(+0.1%) |
| Mar 2011 | - | $65.03M(-16.4%) | $284.76M(+0.3%) |
| Dec 2010 | $284.00M(+22.0%) | $77.75M(+7.5%) | $284.00M(+8.1%) |
| Sep 2010 | - | $72.31M(+3.8%) | $262.71M(+2.6%) |
| Jun 2010 | - | $69.68M(+8.4%) | $256.11M(+4.1%) |
| Mar 2010 | - | $64.26M(+13.8%) | $246.07M(+5.7%) |
| Dec 2009 | $232.86M(+33.1%) | $56.46M(-14.1%) | $232.86M(+23.6%) |
| Sep 2009 | - | $65.71M(+10.2%) | $188.44M(+8.1%) |
| Jun 2009 | - | $59.64M(+16.8%) | $174.36M(-2.4%) |
| Mar 2009 | - | $51.05M(+323.9%) | $178.67M(+2.1%) |
| Dec 2008 | $174.96M(+14.8%) | $12.04M(-76.7%) | $174.96M(-13.9%) |
| Sep 2008 | - | $51.63M(-19.3%) | $203.30M(+7.5%) |
| Jun 2008 | - | $63.95M(+35.1%) | $189.20M(+17.6%) |
| Mar 2008 | - | $47.34M(+17.2%) | $160.94M(+5.6%) |
| Dec 2007 | $152.45M(-12.4%) | $40.39M(+7.6%) | $152.45M(-8.0%) |
| Sep 2007 | - | $37.52M(+5.2%) | $165.67M(+4.9%) |
| Jun 2007 | - | $35.69M(-8.1%) | $157.99M(-4.6%) |
| Mar 2007 | - | $38.85M(-27.5%) | $165.53M(-4.9%) |
| Dec 2006 | $174.05M(+51.0%) | $53.61M(+79.6%) | $174.05M(+22.3%) |
| Sep 2006 | - | $29.85M(-30.9%) | $142.33M(+3.2%) |
| Jun 2006 | - | $43.23M(-8.7%) | $137.88M(+12.5%) |
| Mar 2006 | - | $47.37M(+116.4%) | $122.58M(+6.3%) |
| Dec 2005 | $115.30M(-6.6%) | $21.89M(-13.8%) | $115.30M(-3.1%) |
| Sep 2005 | - | $25.40M(-9.0%) | $119.03M(-0.5%) |
| Jun 2005 | - | $27.92M(-30.3%) | $119.68M(-4.8%) |
| Mar 2005 | - | $40.09M(+56.4%) | $125.68M(+1.8%) |
| Dec 2004 | $123.47M | $25.63M(-1.6%) | $123.47M(-5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2004 | - | $26.05M(-23.2%) | $130.66M(-5.6%) |
| Jun 2004 | - | $33.92M(-10.4%) | $138.36M(-1.6%) |
| Mar 2004 | - | $37.87M(+15.4%) | $140.56M(-4.3%) |
| Dec 2003 | $147.43M(+6.7%) | $32.81M(-2.8%) | $146.85M(-0.9%) |
| Sep 2003 | - | $33.75M(-6.6%) | $148.26M(-1.2%) |
| Jun 2003 | - | $36.12M(-18.2%) | $150.13M(+2.1%) |
| Mar 2003 | - | $44.17M(+29.1%) | $146.99M(+6.3%) |
| Dec 2002 | $138.19M(+23.4%) | $34.22M(-3.9%) | $138.27M(-0.2%) |
| Sep 2002 | - | $35.62M(+8.0%) | $138.49M(+12.2%) |
| Jun 2002 | - | $32.98M(-6.9%) | $123.43M(+5.4%) |
| Mar 2002 | - | $35.44M(+2.9%) | $117.14M(-4.2%) |
| Dec 2001 | $112.03M(+67.8%) | $34.45M(+67.6%) | $122.33M(+19.0%) |
| Sep 2001 | - | $20.56M(-23.0%) | $102.79M(+5.5%) |
| Jun 2001 | - | $26.70M(-34.3%) | $97.47M(+9.5%) |
| Mar 2001 | - | $40.63M(+172.6%) | $89.02M(+14.9%) |
| Dec 2000 | $66.77M(+37.4%) | $14.90M(-2.2%) | $77.45M(+3.5%) |
| Sep 2000 | - | $15.24M(-16.5%) | $74.85M(+12.4%) |
| Jun 2000 | - | $18.25M(-37.2%) | $66.61M(+9.5%) |
| Mar 2000 | - | $29.07M(+136.3%) | $60.86M(+25.4%) |
| Dec 1999 | $48.60M(+56.0%) | $12.30M(+75.7%) | $48.53M(+7.4%) |
| Sep 1999 | - | $7.00M(-44.0%) | $45.18M(+11.3%) |
| Jun 1999 | - | $12.49M(-25.4%) | $40.58M(+16.3%) |
| Mar 1999 | - | $16.74M(+87.1%) | $34.88M(+11.6%) |
| Dec 1998 | $31.14M(+17.1%) | $8.95M(+272.7%) | $31.25M(+14.0%) |
| Sep 1998 | - | $2.40M(-64.7%) | $27.40M(-5.2%) |
| Jun 1998 | - | $6.80M(-48.1%) | $28.90M(-1.0%) |
| Mar 1998 | - | $13.10M(+156.9%) | $29.20M(+9.0%) |
| Dec 1997 | $26.60M(-31.8%) | $5.10M(+30.8%) | $26.80M(-4.3%) |
| Sep 1997 | - | $3.90M(-45.1%) | $28.00M(-15.2%) |
| Jun 1997 | - | $7.10M(-33.6%) | $33.00M(-8.1%) |
| Mar 1997 | - | $10.70M(+69.8%) | $35.90M(-8.7%) |
| Dec 1996 | $39.00M(-1.8%) | $6.30M(-29.2%) | $39.30M(-8.0%) |
| Sep 1996 | - | $8.90M(-11.0%) | $42.70M(+1.9%) |
| Jun 1996 | - | $10.00M(-29.1%) | $41.90M(+2.2%) |
| Mar 1996 | - | $14.10M(+45.4%) | $41.00M(+3.5%) |
| Dec 1995 | $39.70M(+8.2%) | $9.70M(+19.8%) | $39.60M(+1.5%) |
| Sep 1995 | - | $8.10M(-11.0%) | $39.00M(+2.1%) |
| Jun 1995 | - | $9.10M(-28.3%) | $38.20M(+0.3%) |
| Mar 1995 | - | $12.70M(+39.6%) | $38.10M(+3.8%) |
| Dec 1994 | $36.70M(+252.9%) | $9.10M(+24.7%) | $36.70M(+29.2%) |
| Sep 1994 | - | $7.30M(-18.9%) | $28.40M(+24.0%) |
| Jun 1994 | - | $9.00M(-20.4%) | $22.90M(+38.0%) |
| Mar 1994 | - | $11.30M(+1312.5%) | $16.60M(+61.2%) |
| Dec 1993 | $10.40M(-28.3%) | $800.00K(-55.6%) | $10.30M(-27.0%) |
| Sep 1993 | - | $1.80M(-33.3%) | $14.10M(-9.0%) |
| Jun 1993 | - | $2.70M(-46.0%) | $15.50M(+59.8%) |
| Mar 1993 | - | $5.00M(+8.7%) | $9.70M(-33.6%) |
| Dec 1992 | $14.50M(-34.4%) | $4.60M(+43.8%) | $14.60M(+6.6%) |
| Sep 1992 | - | $3.20M(-203.2%) | $13.70M(-12.7%) |
| Jun 1992 | - | -$3.10M(-131.3%) | $15.70M(-33.8%) |
| Mar 1992 | - | $9.90M(+167.6%) | $23.70M(+7.2%) |
| Dec 1991 | $22.10M(-9.4%) | $3.70M(-28.8%) | $22.10M(-16.6%) |
| Sep 1991 | - | $5.20M(+6.1%) | $26.50M(+3.9%) |
| Jun 1991 | - | $4.90M(-41.0%) | $25.50M(-0.4%) |
| Mar 1991 | - | $8.30M(+2.5%) | $25.60M(+4.9%) |
| Dec 1990 | $24.40M(+15.6%) | $8.10M(+92.9%) | $24.40M(+16.7%) |
| Sep 1990 | - | $4.20M(-16.0%) | $20.90M(+2.5%) |
| Jun 1990 | - | $5.00M(-29.6%) | $20.40M(-4.2%) |
| Mar 1990 | - | $7.10M(+54.3%) | $21.30M(-69.8%) |
| Dec 1989 | $21.10M(+6.6%) | $4.60M(+24.3%) | $70.50M(-217.7%) |
| Sep 1989 | - | $3.70M(-37.3%) | -$59.90M(+244.3%) |
| Jun 1989 | - | $5.90M(-89.5%) | -$17.40M(-167.7%) |
| Mar 1989 | - | $56.30M(-144.8%) | $25.70M(+29.1%) |
| Dec 1988 | $19.80M(+20.7%) | -$125.80M(-372.3%) | $19.90M(-57.4%) |
| Sep 1988 | - | $46.20M(-5.7%) | $46.70M(+18.2%) |
| Jun 1988 | - | $49.00M(-3.0%) | $39.50M(+34.4%) |
| Mar 1988 | - | $50.50M(-151.0%) | $29.40M(+79.3%) |
| Dec 1987 | $16.40M(+37.8%) | -$99.00M(-353.8%) | $16.40M(-52.7%) |
| Sep 1987 | - | $39.00M(+0.3%) | $34.70M(+29.5%) |
| Jun 1987 | - | $38.90M(+3.7%) | $26.80M(+38.9%) |
| Mar 1987 | - | $37.50M(-146.5%) | $19.30M(+63.6%) |
| Dec 1986 | $11.90M(+36.8%) | -$80.70M(-359.5%) | $11.80M(-54.8%) |
| Sep 1986 | - | $31.10M(-1.0%) | $26.10M(+27.9%) |
| Jun 1986 | - | $31.40M(+4.7%) | $20.40M(+47.8%) |
| Mar 1986 | - | $30.00M(-145.2%) | $13.80M(+60.5%) |
| Dec 1985 | $8.70M(+141.7%) | -$66.40M(-361.4%) | $8.60M(-51.1%) |
| Sep 1985 | - | $25.40M(+2.4%) | $17.60M(+43.1%) |
| Jun 1985 | - | $24.80M(0.0%) | $12.30M(+55.7%) |
| Mar 1985 | - | $24.80M(-143.2%) | $7.90M(+119.4%) |
| Dec 1984 | $3.60M | -$57.40M(-385.6%) | $3.60M(-94.1%) |
| Sep 1984 | - | $20.10M(-1.5%) | $61.00M(+49.1%) |
| Jun 1984 | - | $20.40M(-0.5%) | $40.90M(+99.5%) |
| Mar 1984 | - | $20.50M | $20.50M |
FAQ
- What is Bio-Rad Laboratories annual earnings before interest & taxes?
- What is the all time high annual EBIT for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual EBIT year-on-year change?
- What is Bio-Rad Laboratories quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly EBIT year-on-year change?
- What is Bio-Rad Laboratories TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories TTM EBIT year-on-year change?
What is Bio-Rad Laboratories annual earnings before interest & taxes?
The current annual EBIT of BIO is -$2.29B
What is the all time high annual EBIT for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual earnings before interest & taxes is $5.45B
What is Bio-Rad Laboratories annual EBIT year-on-year change?
Over the past year, BIO annual earnings before interest & taxes has changed by -$1.49B (-186.45%)
What is Bio-Rad Laboratories quarterly earnings before interest & taxes?
The current quarterly EBIT of BIO is $95.40M
What is the all time high quarterly EBIT for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly earnings before interest & taxes is $5.02B
What is Bio-Rad Laboratories quarterly EBIT year-on-year change?
Over the past year, BIO quarterly earnings before interest & taxes has changed by -$408.00M (-81.05%)
What is Bio-Rad Laboratories TTM earnings before interest & taxes?
The current TTM EBIT of BIO is -$2.70B
What is the all time high TTM EBIT for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high TTM earnings before interest & taxes is $8.57B
What is Bio-Rad Laboratories TTM EBIT year-on-year change?
Over the past year, BIO TTM earnings before interest & taxes has changed by -$2.31B (-584.86%)